Laser Therapy Services Competitors

UVA Health is an academic health system that recently expanded to include four hospitals across Charlottesville, Culpeper and Northern Virginia, along with the UVA School of Medicine, UVA School of Nursing, UVA Physicians Group and the Claude Moore Health Sciences Library. With more than 1,000 inpatient beds, approximately 40,000 inpatient stays annually and more than 1 million outpatient encounters annually at UVA Health, more than 1,000 employed and independent physicians provide high-quality, comprehensive and specialized care to patients across the Commonwealth and beyond. Founded in 1819 as just the 10th medical school in America, the UVA School of Medicine – with 20 clinical departments, nine research departments and seven research centers – consistently attracts some of the nation’s most prominent researchers to develop breakthrough treatments to benefit patients around the world. Those research efforts are backed by more than $200 million in grant funding. UVA Health Children's is recognized as the No. 1 hospital in Virginia for children by U.S. News & World Report, with nine specialties rated among the top in America. For career opportunities, visit https://careers.uvahealth.org/.

Zynex, Inc. founded in 1996, engineers, manufactures and markets stroke rehabilitation and pain management devices. Zynex Medical is a provider of electrotherapy products for home use. Zynex Medical's product line is fully developed, FDA cleared, commercially sold, and has been developed to uphold the company's mission of improving the quality of life for patients suffering from impaired mobility due to stroke or debilitating and chronic pain.

Theralase® Technologies Inc. is a clinical-stage biopharmaceutical company dedicated to the research and development of energy-activated small molecules for the safe and effective destruction of cancer, bacteria, and viruses. Theralase® was one of the first companies in North America to bring Cool Laser Therapy (CLT) to patients and the first company in the world to bring personalized Anti-Cancer Therapy (ACT) to patients based on their individual tissue characteristics.